Identification of senescent-like cells in airway organoids using single cell sequencing
Chronic lung diseases (e.g. chronic obstructive pulmonary disease, cystic fibrosis) are incurable. Epithelial senescence, a state of dysfunctional cell cycle arrest, contributes to the progression of such diseases. We differentiated basal cells to airway (bronchial) organoids. Single cell sequencing showed that the organoids were composed of (transitional) basal, secretory, goblet, deuterosomal and ciliated cells. In addition, we identified a cluster, here defined as senescent cells, with high expression for the common senescence markers CDKN1A (p21), CDKN2A (p16), TIMP2, and GDF15. Senescent cells were marked by an increased activity of the BATF and PRDM1 regulons. Pathway enrichment analysis and analysis of gene set activities showed enrichment of the cellular senescence pathway in the senescent cell cluster. Transitional basal cells and secretory cells showed velocity towards senescent cells. Treatment with the senolytic drug quercitin resulted in a reduced proportion of senescent cells, whereas doxorubicin treatment increased the proportion of goblet cells with increased expression of genes associated with detoxification (e.g. CYP1A1, ALDH13A). Quercetin antagonized doxorubicin-induced activity of senescence associated galactosidase. Further studies need to clarify to what extent such senescent cells are present in the airways of patients with chronic lung diseases and whether they affect the differentiation of the airway epithelium.
Authors
- Kathrin Kattler (ORCID: https://orcid.org/0000-0001-5488-6650)
- Christoph Beißwenger (ORCID: https://orcid.org/0000-0003-4391-3240)
- Michelle Brand
- Felix Ritzmann (ORCID: https://orcid.org/0000-0002-6648-8147)
- Daniela Yildiz (ORCID: https://orcid.org/0000-0002-9702-8581)
Institutions
- Saarland University (DE)
Publication Details
- Published
- 2024-09-14
- DOI
- https://doi.org/10.1183/13993003.congress-2024.pa3504
- Primary Topic
- Tracheal and airway disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00